Anna Michalska-Falkowska

Anna Michalska-Falkowska, PhD, is an expert in the evaluation of research and development projects currently engaged with multiple organizations, including Narodowe Centrum Badań i Rozwoju and the International Society for Biological and Environmental Repositories (ISBER). With a strong background in biobanking, Anna serves as a biobanking specialist on the SARS-HYB45 project, and holds positions such as Chair of the Future Conferences Task Force and Associate Editor for ISBER. In academia, Anna is the Deputy Director of Quality Management at Uniwersytet Medyczny w Białymstoku, overseeing biobanking operations, managing medical records, and conducting research on multi-drug resistance in clinical strains. Anna's education includes a Master of Science in Biobanking from Medizinische Universität Graz and ongoing specialization in Clinical Pharmacy. Collaborative projects with organizations such as Indivumed GmbH and Agencja Badań Medycznych further highlight Anna's extensive involvement in clinical data management and medical research projects.